2001 Vol.19, N°6 - Suppl.25 - Table of contents
Controversies in COX-2 inhibitor therapy
Guest Editors: S.B. Abramson, D.E. Furst, M.C. Hochberg, C. Patrono
Full Papers
CER1973
2001,19,6,Suppl.25
Pg. 0003-0008
Free to view
The role of anti-inflammatory drugs in the treatment of osteoarthritis: a United States viewpoint
R.W. Moskowitz
R.W. Moskowitz
CER1974
2001,19,6,Suppl.25
Pg. 0009-0014
Free to view
The role of anti-inflammatory drugs in the treatment of osteoarthritis: a European viewpoint
M. Dougados
M. Dougados
CER1975
2001,19,6,Suppl.25
Pg. 0015-0022
Free to view
What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective
M.C. Hochberg
M.C. Hochberg
CER1976
2001,19,6,Suppl.25
Pg. 0023-0030
Free to view
NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials ? The gastroenterologist's perspective
C.J. Hawkey
C.J. Hawkey
CER1977
2001,19,6,Suppl.25
Pg. 0031-0036
Free to view
COX-2 inhibitors and the cardiovascular system
G.A. FitzGerald, Y. Cheng, S. Austin
G.A. FitzGerald, Y. Cheng, S. Austin
CER1978
2001,19,6,Suppl.25
Pg. 0037-0040
Free to view
COX-2 inhibitors and the kidney
G.B. Appel
G.B. Appel
CER1979
2001,19,6,Suppl.25
Pg. 0041-0044
Free to view
The effect of NSAIDs on the risk of coronary heart disease: fusion of clinical pharmacology and pharmacoepidemiologic data
L.A. Garcia Rodriguez
L.A. Garcia Rodriguez
CER1980
2001,19,6,Suppl.25
Pg. 0045-0050
Free to view
Measurement of cyclooxygenase isozyme inhibition in humans: exploring the clinical relevance of biochemical selectivity
C. Patrono
C. Patrono
CER1981
2001,19,6,Suppl.25
Pg. 0051-0057
Free to view
Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective
K. Brune, A. Neubert
K. Brune, A. Neubert
CER1982
2001,19,6,Suppl.25
Pg. 0059-0062
Free to view
Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist's perspective
R.O. Day
R.O. Day
CER1983
2001,19,6,Suppl.25
Pg. 0063-0070
Free to view
Analgesia and COX-2 inhibition
R.A. Dionne, A.A. Khan, S.M. Gordon
R.A. Dionne, A.A. Khan, S.M. Gordon
CER1984
2001,19,6,Suppl.25
Pg. 0071-0076
Free to view
Future directions in pain management
D.E. Furst, D.C. Manning
D.E. Furst, D.C. Manning